fatty liver dz Flashcards

1
Q

what makes a liver “fatty”?

A

over 5% steatosis– more white space on histology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Lack of balance between energy in & out → disposal capacity (fructose, sucrose, glucose) → formation and accumulation of intrahepatic fat

A

hepatic steatosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

overarching term for >5% of liver with steatosis; absence of another causes (meds, starvation); little to no alcohol use; v common in DM2

A

NAFLD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what makes NASH diferent from NAFL?

A

NASH has steatosis, hepatocyte ballooning, lobular inflammation, perisinusoidal fibrosis that could progress to cirrhosis; its more severe

NASH= non-alcoholic steatohepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

4 stages of NAFLD disease progression. bold the step that is irreversibel

A

healthy liver →NAFLD → NASH → Cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

bloated hepatocyte, large fat droplets & displaced nucleus

A

NAFLD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

inflamed dying hepatocyte, collagen fibers

A

NASH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

remnants of dead cells, scarring

A

cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

5 conditions associated with NAFL & how?

A

obesity: associated w/ progression
T2DM: most impactful risk factor
HTN: higher incidence as NAFL progresses
dyslipidemia: statins could help
OSA: associated w/ more advanced NAFLD/NASH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

which distribution of body fat has a higher risk of IR, CVD & fibrosis regardless of BMI? which is protective against NAFL?

A
  • android has higher risk (includes waist, belly button)
  • gynoid is protective (starts by bikini line?)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

why is it important to diagnose? (2)

A
  • increased overall mortality & CV death
  • inreased risk of malignancy (GI, kidney, breast)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

relationship between BMI and NASH & NAFL

A

higher BMI more likely to have NASH
lower BMI more likely to have NAFL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

diagnosis of fatty liver (4)

A
  • dx of exclusion; mostly asymptomatic
  • elevated AST & ALT, glucose
  • histology or US showing evidence of heatpic steatosis
  • no other cause of hepatic fat accumulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

4 drugs that could cause hepatic fat accumulation

A

steroids
methotrexate
amiodarone
tamoxifen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

6 d/o that could cause hepatic fat accumulation

A

Hep C
wilsons
lipodystrophy
starvation
parental nutrition
acute fatty liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

primary assessment used to look for patients at risk for advanced fibrosis; age, AST, ALT, platelet count

A

FIB-4 calculator– helps estimate amount of scarring

17
Q
  • secondary assessment that can be done in office or use US-based methods; fairly reliable for advanced fibrosis
  • if advanced fibrosis (over 8) found, refer to GI/hepatology
A

vibration-controlled elastography (VCTE)

18
Q

also used in risk stratification to detect over 5.5% hepatic fat but has limited availability

A

MRI– MR spectroscopy or Elastography

19
Q

reference standard for risk stratification; reserved for diagnostic uncertainty but has limitations related to risk & cost

A

liver biopsy

20
Q

3 general treatment options for fatty liver

A

liver protective behavior
bariatric surgery
medications

21
Q

4 dietary changes to make

A

limit carbs
mediterranean diet
coffee
macronutrient composition

22
Q

3 medication options for fatty liver

A
  • pioglitazone
  • vitamin E 800 IU plant based
  • GLP-1 and SGLT-2i
23
Q

medication that improves AST, ALT, fibrosis but causes weight gain

A

pioglitazone

24
Q

medication that should not be used if at increased risk for prostate cancer or bleeding

A

Vitamin E

25
Q

what do the GLP-1 med names end with? how about the SGLT-2i meds?

A
  • GLP1 ends in “-glutide”
  • SGLT-2i ends in “-gliflozin”